Termination of pregnancy following prenatal diagnosis in France: how severe are the foetal anomalies?
Authors:
- Laurent MandelbrotLMLaurent Mandelbrot
- Isabelle Durand‐ZaleskiIDIsabelle Durand‐Zaleski
- the ICI Group‐Club de médecine foetaleTFthe ICI Group‐Club de médecine foetale
- 21 May 2010
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 30 (6) , 531-539
Abstract
Objective: To determine how severe were the conditions leading to termination of pregnancy for foetal anomaly (TOPFA) in France.Methods: Detailed indications for TOPFA were extracted from medical charts.Results: Of 2465 completed records, indications were: chromosomal anomalies n = 963 (39.1%), malformations of a single organ without chromosomal or genetic aetiologies n = 898 (36.4%), multiple malformations without chromosomal or genetic aetiologies n = 238 (9.7%), obstetrical complications n = 161 (6.5%), non‐chromosomal genetic diseases n = 158 (6.4%), foetal infections n = 21 (0.9%), unexplained severe oligohydramnios n = 20 (0.8%), foetal exposure to teratogenic agents n = 6. Overall, 33.3% of anomalies were lethal (e.g. anencephaly), 25.2% were expected to result in isolated mental retardation (e.g. Down) and 35.1% in substantial handicap (e.g. myelomeningocele). In 6.4% of cases, the anomaly was either of late onset (e.g. Huntington's disease) or with uncertain prognosis (e.g. agenesis of corpus callosum) or severity was debatable (e.g. single limb agenesis, sickle cell disease).Conclusions: Although there is no indisputable definition of which anomalies are ‘severe’, 93.6% of the decisions to terminate the pregnancy were made by women and professionals in reaction to anomalies which clearly were lethal or would lead to substantial physical and/or mental disabilities. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
Funding Information
- ‘Contrat d’Inititation à la Recherche Clinique (CRC03120)
This publication has 13 references indexed in Scilit:
- Long‐term trends for socio‐economic differences in prenatal diagnosis of Down syndrome: diffusion of services or persistence of disparities?BJOG: An International Journal of Obstetrics & Gynaecology, 2008
- Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down’s syndromeBJOG: An International Journal of Obstetrics & Gynaecology, 2008
- Short communication: Termination of pregnancy for fetal anomaly: a population‐based study 1995 to 2004BJOG: An International Journal of Obstetrics & Gynaecology, 2007
- Advances in Medical Technology and Creation of Disparities: The Case of Down SyndromeAmerican Journal of Public Health, 2006
- Prenatal diagnosis of severe structural congenital malformations in EuropeUltrasound in Obstetrics & Gynecology, 2004
- A population‐based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981–2000BJOG: An International Journal of Obstetrics & Gynaecology, 2004
- Ethical Issues in the Management of Pregnancies Complicated by Fetal AnomaliesObstetrical & Gynecological Survey, 2003
- Predictive DNA-testing for Huntington's disease and reproductive decision making: a European collaborative studyEuropean Journal of Human Genetics, 2002
- Decision-making for termination of pregnancies with fetal anomalies: analysis of 53,000 pregnanciesObstetrics & Gynecology, 2002
- Is current practice around late termination of pregnancy eugenic and discriminatory? Maternal interests and abortionJournal of Medical Ethics, 2001